COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 479.4 | 6 | 0055-0243 | 565.44 | 243.58 | 481 | 82.43 | 0.890 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 273.9 | 6 | 0056-0246 | 675.69 | 246.47 | 385 | 73.26 | 0.902 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 200.6 | 6 | 0057-0251 | 200.63 | 251.72 | 394 | 73.84 | 0.908 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 247.8 | 6 | 0058-0254 | 390.06 | 254.58 | 396 | 73.01 | 0.933 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 242.4 | 6 | 0059-0256 | 274.78 | 255.92 | 404 | 76.28 | 0.872 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 215.3 | 6 | 0060-0258 | 297.14 | 258.14 | 451 | 81.36 | 0.856 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 185.3 | 6 | 0061-0258 | 122.38 | 258.27 | 395 | 76.67 | 0.844 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 487.9 | 6 | 0062-0262 | 826.81 | 262.42 | 397 | 77.74 | 0.825 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 219.5 | 6 | 0063-0265 | 364.08 | 265.39 | 397 | 75.50 | 0.875 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 196.5 | 6 | 0064-0266 | 66.07 | 266.07 | 380 | 73.01 | 0.896 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 217.7 | 6 | 0065-0268 | 780.41 | 269.04 | 384 | 78.91 | 0.775 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 192.0 | 6 | 0066-0276 | 942.40 | 276.55 | 414 | 77.26 | 0.872 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 248.2 | 6 | 0067-0284 | 864.62 | 284.60 | 393 | 75.01 | 0.878 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 206.2 | 6 | 0068-0288 | 919.98 | 288.51 | 425 | 80.67 | 0.821 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 241.3 | 6 | 0069-0287 | 25.72 | 287.87 | 402 | 74.18 | 0.918 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 237.5 | 6 | 0070-0291 | 794.39 | 291.48 | 427 | 84.91 | 0.744 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 189.8 | 6 | 0071-0291 | 340.77 | 290.88 | 388 | 74.43 | 0.880 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 200.5 | 6 | 0072-0292 | 733.23 | 292.36 | 414 | 78.08 | 0.853 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 190.3 | 6 | 0073-0302 | 700.29 | 302.29 | 365 | 70.18 | 0.931 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 221.0 | 6 | 0074-0307 | 593.62 | 308.24 | 459 | 83.98 | 0.818 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 174.4 | 6 | 0075-0308 | 389.89 | 307.90 | 416 | 75.60 | 0.915 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 199.8 | 6 | 0076-0316 | 97.64 | 316.85 | 772 | 105.98 | 0.864 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 263.3 | 6 | 0077-0322 | 160.15 | 322.59 | 425 | 78.08 | 0.876 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 384.3 | 6 | 0078-0323 | 429.71 | 323.83 | 412 | 76.43 | 0.886 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | S6 (pS235; pS236) / Alexa Fluor 647 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy5 | S6 (pS235; pS236) | | 222.2 | 6 | 0079-0325 | 620.50 | 325.40 | 390 | 74.67 | 0.879 |